MDT vs SPRY · P/E 21, rev $36.36B vs rev $56.3M
Medtronic PLC (MDT) versus ARS Pharmaceuticals, Inc (SPRY) — a side-by-side from cached financials, not a winner call.
Medtronic PLC (MDT) is a medical devices company listed on US.
ARS Pharmaceuticals, Inc (SPRY) is a biotechnology company listed on NASDAQ.
Latest reported MDT revenue for 2026-04-24 was $36.36B. Net income was $4.80B. Revenue was up 8.4% from 2025-04-25 to 2026-04-24. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
Latest reported SPRY revenue for 2026-06-30 was $56.3M. Net income was -$123.0M. SPRY currently screens at market cap $983.1M.
MDT currently screens at market cap $100.08B and trailing P/E 20.9. SPRY currently screens at market cap $983.1M.
Not investment advice. Open the MDT and SPRY stock pages for the full models.
Not investment advice.